5440-00-6Cn1c(N)c(N)c(=O)n(C)c1=OBGQNOPFTJROKJE-UHFFFAOYSA-Nstructure
5440-00-6DTXSID8063886Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Uses5,6-Diamino-1,3-dimethyl Uracil (cas# 5440-00-6) is a compound useful in organic synthesis.
UsesReactant involved in the synthesis of biologically active molecules including:1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligandsPyrimidinyl purinediones via cyclocondensationTheophylline derivatives as adenosine receptor antagonistsPteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitorsFused tricyclic xanthinesCadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells
Uses5,6-Diamino-1,3-dimethyluracil hydrate can be used as reactant involved in the synthesis of biologically active molecules including: 1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligands ; Pyrimidinyl purinediones via cyclocondensation ; Theophylline derivatives as adenosine receptor antagonists ; Pteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitors ; Fused tricyclic xanthines and Cadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells6.